Alkermes to Participate in the Stifel 2022 CNS Days

<br /> Alkermes to Participate in the Stifel 2022 CNS Days<br />

PR Newswire

DUBLIN

,

March 22, 2022

/PRNewswire/ —

Alkermes plc

(Nasdaq: ALKS) announced today that its Chief Executive Officer,

Richard Pops

, will participate in a fireside chat at the Stifel 2022 CNS Days on

Tuesday, March 29, 2022

at

8:30 a.m. ET

(

1:30 p.m. BST

). The live webcast may be accessed under the Investors tab on

www.alkermes.com

and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at

www.alkermes.com

.

Contact:

Alex Braun

Investor Relations

+1 781 296 8493